Cancer
fromNature
3 days agoIn vivo site-specific engineering to reprogram T cells - Nature
CRISPR-Cas9 enables precise CAR integration into the TRAC locus, improving CAR T cell therapy efficacy while disrupting TCR to reduce graft-versus-host disease in allogeneic approaches.